3
Participants
Start Date
November 30, 2006
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
N-Acetylcysteine
Patients are assigned to either N-Acetylcysteine or placebo. Dose is weight based Placebo is normal saline or D5W
N-Acetylcystine and Non CRRT
Patients are assigned to N-Acetylcysteine and CRRT. The N-Acetylcysteine is blinded to everyone except pharmacy. The CRRT is open label as would be impossible to blind
Placebo and CRRT
Patients are assigned to Placebo and CRRT. The N-Acetylcysteine/Placebo is blinded to everyone except pharmacy. The CRRT is open label
Placebo and Non CRRT
Patients are assigned to Placebo and non-CRRT. The N-Acetylcysteine/placebo is blinded to everyone except pharmacy. The CRRT/non CRRT is open label as would be impossible to blind
King Fahad National Guard Hospital, Riyadh
Royal Alexandra Hospital, Edmonton
University of Alberta
OTHER
Gambro Renal Products, Inc.
INDUSTRY
Royal Alexandra Hospital
OTHER